TRPML3?mediated lysosomal Ca(2+) release enhances drug sequestration and biogenesis, promoting osimertinib resistance in non?small cell lung cancer. Kim MS, Kim MS. Oncol Rep 2025;54:113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim MS, Kim MS. TRPML3?mediated lysosomal Ca(2+) release enhances drug sequestration and biogenesis, promoting osimertinib resistance in non?small cell lung cancer. Oncol Rep 2025;54:113.
PMID: 40682834